{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:41:18Z","timestamp":1762540878552,"version":"build-2065373602"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This project was supported, in part, by funding from Penn State\u2019s Social Science Research Institute (SSRI). Content is the responsibility of the authors and does not represent the views of the SSRI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The opioid epidemic continues to pose significant challenges in the United States, with over 75% of nearly 107,000 drug overdose deaths in 2022 involving opioids. Recently, efforts to curb the epidemic have made strides. Beginning in the early 2000s, local and state governments filed a series of lawsuits against opioid manufacturers and distributors. The lawsuits held that manufacturers and distributors knew about the potential addictive nature of these painkillers and withheld this information from providers, leading to overprescription and overdose. The current settlement funds allotted to Pennsylvania amount to approximately 2 billion USD, can be spent over the next 18\u00a0years, and are distributed at the county level. This paper investigates the early perceptions of local government officials and substance use service providers in Pennsylvania regarding the rollout of settlement funds and their decisions about how to use them.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This paper draws on 66 semi-structured interviews and 6 focus groups conducted in 2023 across six Pennsylvania counties. Interviews were audio-recorded, transcribed and inductively coded using NVivo software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Findings reveal an initial sense of confusion among participants about navigating the funding process, exacerbated by unclear guidelines and insufficient support from state-level officials. Despite these challenges, participants express optimism about the potential for innovative, locally focused projects to effectively address the impacts of the epidemic. Emphasizing the importance of community involvement and transparency, the study highlights a collective commitment to ensuring that funds reach those most affected by the crisis. Yet still, some participants recognized the limits of the settlement funds in addressing the deep trauma that their communities have experienced.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The recommendations underscore the necessity for better systems to outline funding processes, promote best practices, and enhance inter-county collaboration. This research contributes valuable insights into the decision-making dynamics surrounding opioid settlement funds and lays the groundwork for future investigations into their long-term impacts and efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13011-025-00665-7","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:11:13Z","timestamp":1760602273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Initial stakeholder perceptions around opioid settlement funds in Pennsylvania"],"prefix":"10.1186","volume":"20","author":[{"given":"Halie","family":"Kampman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Brant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Sterner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"665_CR1","doi-asserted-by":"publisher","unstructured":"Alexander GC, Mansour O. Distribution of Abatement Funds Arising From US Opioid Litigation. JAMA. 2022;328(19):1901\u20131902.\u00a0https:\/\/doi.org\/10.1001\/jama.2022.19667.","DOI":"10.1001\/jama.2022.19667"},{"key":"665_CR2","unstructured":"Allegheny County. 2025. https:\/\/tableau.alleghenycounty.us\/t\/PublicSite\/views\/OpioidSettlementFundSpending\/ExpenditurestoDateiframeSizedToWindow=true&%3Aembed=y&%3AshowAppBanner=false&%3Adisplay_count=no&%3AshowVizHome=no&%3Aorigin=viz_share_link#1."},{"key":"665_CR3","unstructured":"Center for Disease Control (CDC): Understanding the opioid overdose epidemic. 2024. https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html. Accessed 23 Oct 2024."},{"key":"665_CR4","unstructured":"Center for Rural Pennsylvania. Rural urban definitions. (n.d.)\u00a0https:\/\/www.rural.pa.gov\/data\/rural-urban-definitions. Accessed 24 Oct 2024."},{"issue":"3","key":"665_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s13142-017-0495-z","volume":"7","author":"MS Goodman","year":"2017","unstructured":"Goodman MS, Sanders Thompson VL. The science of stakeholder engagement in research: classification, implementation, and evaluation. Transl Behav Med. 2017;7(3):486\u201391. https:\/\/doi.org\/10.1007\/s13142-017-0495-z.","journal-title":"Transl Behav Med"},{"issue":"24","key":"665_CR6","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1056\/NEJMp1710756","volume":"377","author":"RL Haffajee","year":"2017","unstructured":"Haffajee RL, Mello MM. Drug companies\u2019 liability for the opioid epidemic. N Engl J Med. 2017;377(24):2301\u20135. https:\/\/doi.org\/10.1056\/NEJMp1710756.","journal-title":"N Engl J Med"},{"key":"665_CR7","doi-asserted-by":"publisher","unstructured":"Kent R. A federal role is needed in the opioid litigation settlements. Alcoholism and drug abuse weekly. 2024. https:\/\/doi.org\/10.1002\/adaw.34215.","DOI":"10.1002\/adaw.34215"},{"key":"665_CR8","doi-asserted-by":"publisher","unstructured":"Krawczyk N, Jordan A, Cerd\u00e1 M. Optimizing opioid settlement funds to save lives: investing in equitable solutions. Health affairs forefront. 2023. https:\/\/doi.org\/10.1377\/forefront.20230210.535750.","DOI":"10.1377\/forefront.20230210.535750"},{"key":"665_CR9","unstructured":"Mann B. 4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis. 2022. https:\/\/www.npr.org\/2022\/02\/25\/1082901958\/opioid-settlement-johnson-26-billion. Accessed 23 Oct 2024."},{"key":"665_CR10","unstructured":"Overdose Free PA. View county death data. (n.d.). https:\/\/www.overdosefreepa.org\/know-the-facts\/view-overdose-death-data\/. Accessed 7 May 2025."},{"key":"665_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40900-023-00433-6","volume":"9","author":"J Petkovic","year":"2023","unstructured":"Petkovic J, Magwood O, Lytvyn L, et al. Key issues for stakeholder engagement in the development of health and healthcare guidelines. Res Involv Engagem. 2023;9:27. https:\/\/doi.org\/10.1186\/s40900-023-00433-6.","journal-title":"Res Involv Engagem"},{"key":"665_CR12","unstructured":"Pierson, B. Pharmacies, drug companies settle lawsuits over U.S. opioid crisis. Reuters. 2024. https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/pharmacies-drug-companies-settle-lawsuits-over-us-opioid-crisis-2022-11-22\/.4. Accessed 24 Oct 2024."},{"key":"665_CR13","doi-asserted-by":"publisher","unstructured":"Rhubart D, Chen Q, Sterner G, Newton R, Shaw B, Scanlon D. Conceptualizing and measuring abatement from the opioid epidemic: a case study from Pennsylvania. Milbank Q. 2022. https:\/\/doi.org\/10.1111\/1468-0009.12589.","DOI":"10.1111\/1468-0009.12589"},{"key":"665_CR14","doi-asserted-by":"crossref","unstructured":"Salda\u00f1a J. Thinking qualitatively: methods of mind. SAGE Publications:\u00a0Thousand Oaks USA, 2014.","DOI":"10.4135\/9781071909782"},{"key":"665_CR15","doi-asserted-by":"publisher","unstructured":"Saucier R, Christensen T, Minhee C, Evans S. How are opioid settlement funds being spent so far? Health affairs forefront. 2023. https:\/\/doi.org\/10.1377\/forefront.20231120.523543.","DOI":"10.1377\/forefront.20231120.523543"},{"key":"665_CR16","unstructured":"U.S. Census Bureau. 2018\u20132022 5-year American community survey estimates. 2023; data.census.gov. Accessed 24 Oct 2024."},{"key":"665_CR17","unstructured":"Unites States Judicial Panel on Multidistrict Litigation. In Re: National Prescription Opiate Litigation. Case 1:17-md-02804-DAP; 2017."},{"key":"665_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.4017","author":"S Whaley","year":"2023","unstructured":"Whaley S, Sharfstein J. The opioid settlements\u2014will the first steps be in the right direction? JAMA Health Forum. 2023. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.4017.","journal-title":"JAMA Health Forum"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-025-00665-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-025-00665-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-025-00665-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:11:18Z","timestamp":1760602278000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-025-00665-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1186\/s13011-025-00665-7","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The Pennsylvania State University\u2019s Institutional Review Board for human subjects research. All participants provided informed consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}